HI
HUMA icon

HBK Investments’s Humacyte HUMA Stock Holding History

HBK Investments’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$617K Buy
+790,000
New +$732K 0.01% 224
2021
Q3 		– Sell
-25,000
Closed -$255K – 805
2021
Q2 		$255K Buy
+25,000
New +$258K ﹤0.01% 659

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HBK Investments's HUMA Position: Q2 2026 in Review

HBK Investments opened a new position in Humacyte (HUMA) in Q2 2026: 790,000 shares worth $617K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings. This is a return to the name: HBK Investments previously reported a position in HUMA as recently as Q2 2021.

HBK Investments first reported a position in HUMA in Q2 2021 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • HBK Investments held 790,000 shares of Humacyte worth $617K as of Q2 2026.
  • Humacyte was a new HBK Investments position in Q2 2026.
  • Humacyte made up 0.01% of HBK Investments's portfolio in Q2 2026, its #224 holding.
  • HBK Investments first reported a position in Humacyte in Q2 2021 and has held it in 2 quarters since.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on HBK Investments's 13F filing for Q2 2026, filed 14 Aug 2026.